Home / Clinical Research / Akebia 2

Akebia 2

Akebia 2 Clinical Research Study

To apply for this study or to find out more information, come into our main office or contact:
Melissa Bartel
Research Coordinator

Main Office

315 N San Saba, Suite 102
San Antonio, TX, 78207

Compensation provided for time & travel
Duration: TBA

If you are unsure if you meet the requirements, call us to schedule a screening and we will determine if  you are eligible or ineligible for this study.

Inclusion Criteria
If you meet these requirements, you can qualify for this study:
1. At least 18 years of age
2. Receiving chronic maintenance dialysis (either peritoneal or hemodialysis) for end stage kidney disease for at least 12 weeks prior to Screening
3. Currently maintained on ESA therapy, with the last dose received within 8 weeks prior to Screening
4. Mean screening Hb between 8.0 and 11.0 g/dL (inclusive) in the US and between 9.0 and 12.0 g/dL (inclusive) outside of the US, as determined by the average of 2 Hb values measured by the central laboratory during Screening.
5. Serum ferritin > 100 ng/mL and transferrin saturation (TSAT) >20% during Screening.
6. Folate and vitamin B12 measurements > lower limit of normal (LLN) during Screening
7. Understands the procedures and requirements of the study and provides written informed consent and authorization for protected health information disclosure.

Again, if you are unsure if you or someone you know could qualify for this study, call us and we will be happy to schedule you a research screening.